I agree with the rooster. If I owned a an F/A 22 Raptor I would want a top gun US Air Force pilot to fly it, not some Russian Mig 29 Pilot . See if you gave the Russian pilot the best jet fighter in the world he would crash it, not because he is not smart but because he has no idea what he is doing. He may tell you he knows what he is doing, hire other pilots to help him fly it. But bottom line, as long as he is in the cockpit, he is going to crash it. And to date we haven't even been able to get off the runway, let alone someday get into a dog fight and you think just because we have the F/A 22 Raptor that Foolishstein and Jerkovv will be able to do it. Those proven clowns need to be in the circus not the executive board room.
That is all interesting, but CBLI is not Pfizer, Merck or Bristol Meyer. Those companies have actually accomplished something and know what they are doing.
Other than personally enriching themselves, what have they done for the shareholders (who actually paid money for their shares)? Anyone care to illustrate how they have enriched shareholders? They should be embarrassed.
Yakov Kogan, the chief executive officer of Cleveland BioLabs Inc., earned $668,244 in 2012. Kogan was named interim CEO in January 2012 — the interim tag was removed in June. He earned $1.09 million in 2011 and $580,203 in 2010 as chief operating officer.
Kogan and other Cleveland BioLabs executives saw their pay drop in 2012 mostly as a result of large decreases in their stock option awards. Cleveland BioLabs filed its preliminary proxy statement on May 7. The company reported May 9 that it lost $9.8 million in the first quarter.
Michael Fonstein, who serves as the company’s president and retired as its CEO in January 2012, earned $540,593 in 2012, down from $1.16 million in 2011 and $631,868 in 2010.
C. Neil Lyons, the company’s chief financial officer, earned $304,051 in 2012 and $310,880 in 2011. Lyons was appointed CFO in September 2011.
Andrei Gudkov, chief scientific officer, earned $351,401 in 2012, $952,915 in 2011 and $457,431 in 2010.
I think they get paid way too much for having accomplished nothing but net losses for their shareholders. All they have done to date is some basic science research. Universities don't pay their employees that much.
Well it looks like some people get disappointed and some other people bet against the bad management. Its hard to deny that people are becoming more emboldened that the company is going the wrong way:
What do they know?
Were you privy to a recent meeting at the mother ship? If so, I totally concur. If not, you may be clairvoyant, and I still agree with your first prophetic posting, and from now on shall be referred to as "the oracle of Biolabs". Sleep well brother. :)
JV must be done or nearly done in principal..
"What would they say at a hearing?"
Senator: "So you are telling me we have a product that has been safely tested on hundreds of people and found to be safe and the only appreciable side effect noted were flu like symptoms?
Senator: And this product saved the lives of 70% of the monkeys who were exposed to it versus placebo?
Senator" What other products do we have for this type of situation?
Senator: So am I to understand that we have held up funding and development of this product for over a year because we wanted to redesign the mouse study because we were worried about a liver metabolite that exist in the mice but not the humans that made some of the mice die, and we knew the metabolite producing pathway does not exist in humans?
Senator : Did you ever think that maybe it would have been OK with the people of Boston if some of the mice and rats possibly die and the people survived this nuclear event.
BARDA: We were worried about the mice that died as a result of a metabolite that does not exist in humans and wanted to clearly elucidate the LD50. We love mice
Senator: You have got to be Fucqing kidding me. No further question.
"Did a quick check to see if there were any other similar solicitations by other companys to Barda & all i could find was Maxygen & their request was declined after exactly 27 weeks (189 days) back in 2009. "
Thanks for giving me a sick feeling in the pit of my stomach. Joy to you too.
They have said they will announce a rejection as soon as they are notified.
They have also said they will only announce a signed deal. So, they will not notify us if they are discussing or negotiating any of the finer points or particulars of the grant. So although, they may know the general outline of the grant by the 18th they are not letting anyone know until it is all in writing and is signed. They seemed a little paranoid if you ask me, but again what do I know, I don't walk in their shoes.
My guess is that we hear no response by April 18th, which I interpret as good news. I believe that we get the grant(~50 million) and stuck in the grant proposal is an EUA, which gets authorized soon given recent world events.(remember we have the only TOTAL BODY radiation product out there and nobody is close) We hear from BARDA in late April or early May. If I am wrong then we have a JV that is announced this week for 502 or 137, although good news , I hope not.
TOKYO—Japan's nuclear regulator said on Sunday that up to 167 metric tons of contaminated water has seeped into soil from underground storage pools at the site of the stricken Fukushima Daiichi nuclear power plant after additional leaks were found. The discovery of the leaks underscores the difficulties plant operator Tokyo Electric Power Co. 9501.TO +1.02% faces in trying to safely store the vast and still increasing amounts of contaminated water that have been used to cool reactors and spent fuel at Fukushima Daiichi.
The leaks follow two recent glitches with the reactors' makeshift cooling systems that generate the contaminated water, including a power outage on Friday.
About 400 tons a day of contaminated water is produced by the cooling operations needed to keep fuel from overheating and reacting at the plant. While radioactive cesium is removed from the water after use, other radioactive materials remain in it. Tepco has been storing the contaminated water on site in tanks and pools, but still lacks a longer-term solution to decontaminate the water.
The Nuclear Regulation Authority said Saturday that up to 120 tons of contaminated water had leaked into nearby soil from one of seven underground pools at the Fukushima Daiichi nuclear power plant. On Sunday, it said a further 47 tons may have leaked while Tepco tried to pump the water to an adjacent pool, adding that a smaller leak had also been discovered at another pool.
The main leaking pool is about 60 meters (200 feet) long, 53 meters wide and 6 meters deep, and is lined with three layers of waterproof sheets. About 13,000 tons of contaminated water was in the pool as of Saturday.
The authority said the operation to transfer the water is expected to take about three days.
According to the Nuclear Regulation Authority, radioactive substances were detected around the layers lining the pools, suggesting a breach.
Disagree, No way we go past April 18th and get bad news. Makes no logical sense, unless they were intentially trying to cause financial harm to Biolabs, in fact, I would argue that a negative response at this late date is would be malicious posturing by BARDA.
I would think that if we hear no news by the 18th that this non event is good news. Reason being, BARDA has been working with Biolabs on this matter for over a year, and it clearly doesn't take over a year to say NO.